DrugPatentWatch Database Preview
Drugs in Development Information for Sodium propionate
» See Plans and Pricing
What is the drug development status for Sodium propionate?
Sodium propionate is an investigational drug.
There have been 4 clinical trials for Sodium propionate.
The most recent clinical trial was a Phase 3 trial, which was initiated on September 1st 1993.
The most common disease conditions in clinical trials are Asthma, Lung Diseases, and Bronchiolitis Obliterans. The leading clinical trial sponsors are National Heart, Lung, and Blood Institute (NHLBI), Lee, Stephanie, and National Cancer Institute (NCI).
Summary for Sodium propionate
| US Patents | 0 |
| International Patents | 0 |
| US Patent Applications | 36 |
| WIPO Patent Applications | 0 |
| Japanese Patent Applications | 0 |
| Clinical Trial Progress | Phase 3 (1993-09-01) |
| Vendors | 51 |
Recent Clinical Trials for Sodium propionate
| Title | Sponsor | Phase |
|---|---|---|
| Targeted Therapy of Bronchiolitis Obliterans Syndrome | National Cancer Institute (NCI) | Phase 2 |
| Targeted Therapy of Bronchiolitis Obliterans Syndrome | Lee, Stephanie | Phase 2 |
| Montelukast Asthmatic Smoker Study (0476-332)(COMPLETED) | Merck Sharp & Dohme Corp. | Phase 3 |
Clinical Trial Summary for Sodium propionate
Top disease conditions for Sodium propionate
Top clinical trial sponsors for Sodium propionate
US Patents for Sodium propionate
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
